News about Market

GVRP and Steps Biosciences Launch Advanced Formulations Research Centre in Bengaluru

GVRP and Steps Biosciences have inaugurated the GVRP StepsBio Research Centre (GSRC) at Bengaluru’s Lifescapes life sciences cluster, strengthening India’s pharmaceutical innovation ecosystem with advanced facilities for complex formulations, sterile injectables, analytical testing and AI-enabled drug development.

Market | 06/06/2026 | By News Bureau

Teva Pharma Launches AHZANTIVE Biosimilar to Eylea in Europe

Teva has launched AHZANTIVE (aflibercept), an EMA-approved biosimilar to Eylea, across Europe. Demonstrating comparable efficacy, safety, and immunogenicity to the reference product, the launch expands Teva’s biosimilars and ophthalmology portfolio while supporting its long-term Pivot to Growth strategy.

Market | 06/06/2026 | By News Bureau

Gilead and Lakefront Complete Acquisition of Ouro Medicines

Gilead Sciences and Lakefront have completed the acquisition of Ouro Medicines, expanding their inflammation and autoimmune disease pipeline. The companies will jointly advance gamgertamig, a potential first-in-class and best-in-class T-cell engager therapy designed to address unmet needs in autoimmune disorders.

Market | 05/06/2026 | By News Bureau

Glenmark Launches Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials

Glenmark Pharmaceuticals Inc., USA has launched Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), a bioequivalent and therapeutically equivalent generic version of Vimpat Injection.

Market | 05/06/2026 | By News Bureau

Novo Nordisk Launches Wegovy Weight-Loss Pill in UAE, First Market Outside the US

UAE becomes first country outside the United States to offer the oral semaglutide treatment for obesity, marking a key step in Novo Nordisk’s global expansion plans.

Market | 04/06/2026 | By News Bureau

iiCON Secures European Funding to Lead Pan-European Network on Infectious Disease Preparedness

iiCON will lead a Europe-wide collaboration bringing together researchers, healthcare experts, policymakers and industry partners to develop coordinated solutions for emerging infectious disease threats.

Market | 03/06/2026 | By News Bureau

Alkem Brings Semaglutide Pre-Filled Syringes to Indian Market

Alkem has launched semaglutide pre-filled syringes in India, introducing a convenient single-shot administration option for the management of Type 2 Diabetes (T2D) and obesity.

Market | 03/06/2026 | By News Bureau

Pfizer Launches Elranatamab in India for Relapsed or Refractory Multiple Myeloma

Pfizer has launched Elranatamab in India for adults with Relapsed or Refractory Multiple Myeloma (RRMM) who have received at least four prior therapies. The BCMA-directed bispecific antibody is available as a fixed-dose subcutaneous injection, offering a novel treatment option for heavily pretreated multiple myeloma patients.

Market | 03/06/2026 | By News Bureau

Hanmi Signs Licensing Agreement with Lilly for Sonefpeglutide

Hanmi has signed a licensing agreement with Lilly for sonefpeglutide (LAPSGLP-2 analog), granting rights to develop and commercialize the investigational therapy across multiple indications.

Market | 03/06/2026 | By News Bureau

Marksans Pharma Acquires Netherlands-Based QliniQ B.V. to Strengthen Europe Business

Marksans Pharma is set to acquire Netherlands-based QliniQ BV, a strategic move that expands its footprint in regulated European markets and strengthens its forward-integration strategy through direct market-access capabilities across the European Union (EU).

Market | 01/06/2026 | By News Bureau |  134